X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (136292) 136292
Journal Article (17333) 17333
Trade Publication Article (14474) 14474
Magazine Article (8382) 8382
Web Resource (7667) 7667
Book Review (2701) 2701
Report (1687) 1687
Publication (758) 758
Book Chapter (307) 307
Government Document (278) 278
Conference Proceeding (119) 119
Transcript (76) 76
Book / eBook (19) 19
Dissertation (14) 14
Data Set (7) 7
Paper (2) 2
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fda approval (181924) 181924
pharmaceutical industry (48436) 48436
clinical trials (29796) 29796
patients (18426) 18426
regulatory approval (16369) 16369
prescription drugs (14151) 14151
drug dosages (13968) 13968
research & development--r&d (13745) 13745
cancer therapies (11934) 11934
medical equipment (11551) 11551
product development (11059) 11059
studies (10587) 10587
pharmaceuticals (9562) 9562
investments (9513) 9513
cancer (8587) 8587
stock exchanges (8474) 8474
corporate profits (8458) 8458
earnings per share (8350) 8350
stockholders (7961) 7961
drugs (7741) 7741
medical research (7676) 7676
index medicus (7631) 7631
biotechnology industry (7464) 7464
diabetes (7428) 7428
business metrics (7328) 7328
acquisitions & mergers (7251) 7251
marketing (6974) 6974
oncology (6882) 6882
net losses (6855) 6855
metastasis (6779) 6779
humans (6760) 6760
pain (6586) 6586
financial performance (6473) 6473
generic drugs (6335) 6335
chemotherapy (6327) 6327
drug therapy (6327) 6327
manufacturing (6309) 6309
disease (5605) 5605
tumors (5435) 5435
webcasting (5363) 5363
collaboration (5319) 5319
womens health (5231) 5231
narcotics (5015) 5015
appointments & personnel changes (4910) 4910
pediatrics (4892) 4892
medicine (4791) 4791
laboratories (4771) 4771
breast cancer (4729) 4729
hospitals (4721) 4721
infections (4595) 4595
present value (4380) 4380
vaccines (4306) 4306
agreements (4271) 4271
research (4107) 4107
food (4048) 4048
drug approval (4022) 4022
transplants & implants (3930) 3930
candidates (3909) 3909
surgery (3816) 3816
profit margins (3804) 3804
chief executive officers (3800) 3800
mutation (3787) 3787
patents (3766) 3766
leukemia (3764) 3764
lymphomas (3708) 3708
administrative expenses (3700) 3700
capital losses (3653) 3653
sales (3591) 3591
immunotherapy (3562) 3562
litigation (3536) 3536
proteins (3353) 3353
equity (3342) 3342
researchers (3314) 3314
lung cancer (3303) 3303
care and treatment (3187) 3187
intellectual property (3159) 3159
cardiovascular disease (3152) 3152
antibiotics (3132) 3132
capital gains (3114) 3114
short sales (3063) 3063
public health (3062) 3062
hepatitis (3030) 3030
medical technology (2903) 2903
stem cells (2759) 2759
physicians (2670) 2670
federal regulation (2654) 2654
biological products (2550) 2550
melanoma (2525) 2525
mortality (2504) 2504
united states (2485) 2485
arthritis (2474) 2474
proprietary (2471) 2471
safe harbor (2445) 2445
hypertension (2440) 2440
commercialization (2415) 2415
heart failure (2391) 2391
alzheimers disease (2383) 2383
pharmacology & pharmacy (2380) 2380
human immunodeficiency virus--hiv (2371) 2371
stock prices (2362) 2362
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Robarts - Stacks (8) 8
Gerstein Science - Stacks (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
UofT at Mississauga - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (183594) 183594
French (268) 268
Spanish (249) 249
German (244) 244
Italian (59) 59
Portuguese (14) 14
Turkish (11) 11
Chinese (7) 7
Hindi (7) 7
Urdu (5) 5
Czech (2) 2
Dutch (2) 2
Japanese (2) 2
Korean (2) 2
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, Princeton studies in American politics : historical, international, and comparative perspectives., ISBN 0691141800, xx, 802
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield... 
Drugs | Pharmaceutical policy | Consumer Product Safety | Government Regulation | Government Agencies | Drug Approval | Research | history | Organizational Culture | United States. Food and Drug Administration | United States | History | Political Science | Health Sciences | Food and Drug Administration
Book
Transfusion, ISSN 0041-1132, 12/2017, Volume 57, Issue 12, pp. 2836 - 2844
BACKGROUNDLaboratory and clinical evidence suggest that cold‐stored platelets (CS‐PLTs) might be preferable to room temperature platelets (RT‐PLTs) for active... 
Regulatory agencies | Agitation | Food contamination | Shelf life | FDA approval | Cold storage | Patients | Trauma | Bleeding | Clotting | Risk factors | Regulatory approval | Storage | Bacteria | Platelets | Ambulances
Journal Article
JAMA, ISSN 0098-7484, 11/2017, Volume 318, Issue 19, pp. 1861 - 1862
Approval of the drug tisagenledeucel (Kymriah; Novartis) by the US Food and Drug Administration (FDA) for the treatment of pediatric and young adult acute... 
MEDICINE, GENERAL & INTERNAL | Regulatory agencies | Reminder | Acute lymphatic leukemia | Revenues | Leukemia | Norms | Oncology | FDA approval | Lymphatic leukemia | Cancer therapies | Patients | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Obstetrics & Gynecology, ISSN 0029-7844, 06/2016, Volume 127, Issue 6, pp. 1110 - 1117
Recent controversies surrounding obstetrics and gynecology devices, including a permanent sterilization device, pelvic meshes, and laparoscopic morcellators,... 
UNITED-STATES | 21ST-CENTURY CURES ACT | FDA | OBSTETRICS & GYNECOLOGY | United States | Gynecology | Humans | Product Surveillance, Postmarketing | Female | Obstetrics | Device Approval | United States Food and Drug Administration | Databases, Factual | Randomized Controlled Trials as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Drugs, ISSN 0012-6667, 8/2017, Volume 77, Issue 12, pp. 1369 - 1376
Intravenous durvalumab (Imfinzi™; AstraZeneca) is a fully human monoclonal antibody that blocks programmed cell death ligand-1 binding to its receptors (PD-1... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | POPULATION | PD-L1 ANTIBODY | NAIVE PATIENTS | SAFETY | TOLERABILITY | TREMELIMUMAB | PHARMACOLOGY & PHARMACY | TOXICOLOGY | JAPANESE PATIENTS | MEDI4736 | COMBINATION | PHASE-I | United States | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Drug Approval | Urothelium - pathology | Urologic Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Transitional Cell - drug therapy | United States Food and Drug Administration | Care and treatment | Carcinoma | Drug therapy | Cancer | Intravenous administration | PD-1 protein | Lung cancer | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Cancer therapies | Metastases | Receptors | Human papillomavirus | Platinum | Neck | Urothelial carcinoma | Medical research | Squamous cell carcinoma | Head | Small cell lung carcinoma | Hematology | Melanoma | Non-small cell lung carcinoma | CD80 antigen | T cell receptors | Lung carcinoma | FDA approval | Gene expression | Bladder cancer | Chemotherapy | Cell death | Medical prognosis | Monoclonal antibodies | Head and neck cancer | Ligands | Solid tumors | Tumors | Apoptosis | Index Medicus | AdisInsight Report
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2014, Volume 371, Issue 8, pp. 689 - 691
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. 2924 - 2927
Journal Article
Drugs, ISSN 0012-6667, 1/2019, Volume 79, Issue 1, pp. 99 - 103
Journal Article
Drugs, ISSN 0012-6667, 5/2019, Volume 79, Issue 7, pp. 779 - 783
Journal Article
Drugs, ISSN 0012-6667, 2/2019, Volume 79, Issue 3, pp. 325 - 329
Journal Article
Drugs, ISSN 0012-6667, 6/2019, Volume 79, Issue 9, pp. 1009 - 1015
Siponimod (Mayzent ® ) is an oral selective sphingosine 1-phosphate receptor subtypes 1 and 5 (S1PR1,5) modulator being developed by Novartis Pharmaceuticals... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | PHARMACOKINETICS | SAFETY | TOLERABILITY | RECEPTOR MODULATORS | BAF312 | PHARMACOLOGY & PHARMACY | OPEN-LABEL | BOLD | TOXICOLOGY | IMPAIRMENT | Cardiac arrhythmia | Neurology | Multiple sclerosis | Lymphatic system | Lymphocytes | Medical services | Nervous system | FDA approval | Hemorrhage | Drug dosages | Sphingosine 1-phosphate
Journal Article
Drugs, ISSN 0012-6667, 6/2019, Volume 79, Issue 9, pp. 1023 - 1029
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 1/2019, Volume 79, Issue 1, pp. 93 - 98
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 5/2019, Volume 79, Issue 7, pp. 785 - 790
Journal Article